---
category: news
title: "Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development"
excerpt: "Technology creates Digital Twins and Intelligent Control Arms to reduce clinical trial timelines and improve confidence in trial results Unlearn.AI, developer of the first machine-learning (ML) platform that creates Digital Twins to populate Intelligent Control Arms in clinical studies, today presented results generated from the company’s ..."
publishedDateTime: 2019-12-09T00:01:00Z
sourceUrl: https://finance.yahoo.com/news/unlearn-ai-announces-results-generated-020000636.html
type: article
quality: 4
heat: -1
published: false

provider:
  name: YAHOO!
  domain: yahoo.com

topics:
  - AI
  - Machine Learning

related:
  - title: "Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development"
    excerpt: "SAN FRANCISCO--(BUSINESS WIRE)--Unlearn.AI, developer of the first machine-learning (ML) platform that creates Digital Twins to populate Intelligent Control Arms in clinical studies, today presented results generated from the company’s latest Alzheimer’s disease model at the Clinical Trials on Alzheimer’s Disease (CTAD) meeting in San Diego."
    publishedDateTime: 2019-12-08T02:12:00Z
    sourceUrl: https://www.businesswire.com/news/home/20191207005014/en/Unlearn.AI-Announces-Results-Generated-First-of-its-Kind-Machine-Learning
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 24
    images:
      - url: https://www.bing.com/th?id=ON.1FAC8877B4761C92DE855888D8641A6A
        width: 700
        height: 365
  - title: "Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development"
    excerpt: "Unlearn.AI, developer of the first machine-learning (ML) platform that creates Digital Twins to populate Intelligent Control Arms in clinical studies, today presented results generated from the company’s latest Alzheimer’s disease model at the Clinical Trials on Alzheimer’s Disease (CTAD) meeting in San Diego. The results presented during ..."
    publishedDateTime: 2019-12-13T18:25:00Z
    sourceUrl: https://apnews.com/Business Wire/5dc52889e1d44880904a35878b8e2cf3
    type: article
    provider:
      name: Associated Press News
      domain: apnews.com
    quality: 24
    images:
      - url: https://apnews.com/images/PaidContent3.png
        width: 700
        height: 450

secured: "Z5UDe/H1pdGmwrjDbAMvb14sm+/wEGhicDp6EecMuLoQWABUxoKaKDc9ejyOsHCz3MMrTlqEnAaUqMlvMBvFfwqY35cOkDGPjrHdNwDSFnz3UAAzUfmoGrNjoGCC3PS9iCUcsgvt3+eju6k1qwjtUR/1U5uCrizMDLC0jfHyRI1QWoGBC5lO+FTeB720TSJyGnIlItVOySdTT6vW3rPJgH597/CJMbbyjZiMKIaQJYHlCjHxsy3BcpaQYHwdtd9L8uroc9P1xydYETL5zcPyGA==;atNUJ3WXr1ZDg16ANGf0kQ=="
---

